National Trial of CGM in Pregnant Women With Type 2 Diabetes

NANot yet recruitingINTERVENTIONAL
Enrollment

200

Participants

Timeline

Start Date

March 31, 2026

Primary Completion Date

December 31, 2026

Study Completion Date

December 31, 2026

Conditions
Type 2 DiabetesPregnancy
Interventions
DEVICE

continous glucose monitoring

Pregnant women with type 2 diabetes are given a sensor \< week 14 of their pregnancy and will use it until 4-6 post partum. They will receive training in how to use the sensor, and support when needed.

All Listed Sponsors
collaborator

Steno Diabetes Center Odense

OTHER

collaborator

Steno Diabetes Center Copenhagen

OTHER

collaborator

Steno Diabetes Center Aarhus (SDCA), Aarhus University Hospital

UNKNOWN

collaborator

Steno Diabetes Center Nordjylland

OTHER

lead

Odense University Hospital

OTHER